| Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer—A protocol for systematic review and meta-analysis C Kumarasamy, S Sabarimurugan, RM Madurantakam, K Lakhotiya, ... Medicine 98 (24), e14834, 2019 | 109 | 2019 |
| Diagnostic and prognostic role of HE4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis C Kumarasamy, MR Madhav, S Sabarimurugan, K Lakhotiya, V Pandey, ... Medicine 98 (28), e15336, 2019 | 14 | 2019 |
| Prognostic significance of Lymph Node Ratio (LNR): clinical insights and strategies for routine clinical practice R Jayaraj, C Kumarasamy, S Sabarimurugan, MR Madhav, K Lakhotiya, ... Oral Oncology 91, 125-127, 2019 | 6 | 2019 |
| Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies S Sabarimurugan, C Kumarasamy, MM Royam, K Lakhotiya, ... Medicine 98 (12), e14570, 2019 | 6 | 2019 |
| Deficiency of miR-409-3p improves myocardial neovascularization and function through modulation of DNAJB9/p38 MAPK signaling F Bestepe, C Fritsche, K Lakhotiya, CE Niosi, GF Ghanem, GL Martin, ... Molecular Therapy-Nucleic Acids 32, 995-1009, 2023 | 3 | 2023 |
| Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors K Prasad, N Devaraju, A George, NS Ravi, G Mahalingam, V Rajendiran, ... Molecular Therapy-Nucleic Acids, 2024 | | 2024 |
| 354-OR: Attenuation of Obesity-Induced Vascular Inflammation by microRNA-485 in Endothelial Cells F BESTEPE, R PAL-GHOSH, C FRITSCHE, K LAKHOTIYA, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Precise modelling and correction of a spectrum of β-thalassemic mutations in human erythroid cells by base editors K Prasad, N Devaraju, A George, NS Ravi, G Mahalingam, V Rajendiran, ... bioRxiv, 2022.06. 01.494256, 2022 | | 2022 |
| Prognostic significance of Lymph Node Ratio (LNR): Clinical insights and strategies for routine clinical practice O Oncology xxx xxxx xxx–xxx | | |
